NCT04954118 A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation Status COMPLETED Phase NA
NCT04953247 Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19 Status COMPLETED Phase N/A
NCT04952350 Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT Status UNKNOWN Phase PHASE3
NCT04948203 Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04933799 IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation. Status UNKNOWN Phase PHASE2
NCT04917523 Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above Status COMPLETED Phase PHASE3
NCT04915001 An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province Status COMPLETED Phase N/A
NCT04913779 Safety and Effectiveness of an Immunobiological Drug in CoViD-19 Status UNKNOWN Phase PHASE2/PHASE3
NCT04912011 Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19. Status UNKNOWN Phase PHASE4
NCT04905875 Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry Status UNKNOWN Phase N/A
NCT04901689 Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation Status SUSPENDED Phase PHASE3
NCT04901676 Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia Status SUSPENDED Phase PHASE3
NCT04900454 Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19 Status COMPLETED Phase PHASE1